Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Adverse effects associated with BPC-157 are minimal, with only mild and temporary discomfort reported at the injection site or minor gastrointestinal disturbances in some cases
Liraglutide, the active comparator, was initiated at 0.6 mg daily and titrated weekly up to 3.0 mg
(2021), most patients see measurable improvements within 36 months of consistent use, with continued improvement up to 12 months
1b, Supplementary Fig
Despite these potential benefits, it is important to approach BPC 157 with caution due to concerns about its effects on tumor growth and the lack of extensive human clinical research 4
npj Parkinson's Disease 2 , 16002 (2016)
US$ 28.82
US$ 20.14
US$ 20.72
US$ 28.25
US$ 24.39
US$ 24.22
US$ 23.46
US$ 25.54
